Clinical Impact of the COVID-19 Pandemic in Mexican Patients with Thoracic Malignancies

CONCLUSION: Treatment adjustments in patients with thoracic malignancies often occurred to avoid COVID-19 contagion with detrimental effects on survival. Psychological disorders could have a role in adherence to the original treatment regimen.IMPLICATIONS FOR PRACTICE: The pandemic has placed an enormous strain on health care systems globally. Patients with thoracic cancers represent a vulnerable population, with increased morbidity and mortality rates. In Mexico, treatment modifications were common during the pandemic, and those who experienced delays had worse survival outcomes. Most treatment modifications were related to a patient decision rather than a lockdown of health care facilities in which mental health impairment plays an essential role. Moreover, the high case fatality rate highlights the importance of improving medical care access. Likewise, to develop strategies facing future threats that may compromise health care systems in non-developed countries.PMID:34498780 | DOI:10.1002/onco.13962

Source: The Oncologist - September 9, 2021 Category: Cancer & Oncology Authors: Oscar Arrieta Luis Lara-Mej ía Elysse Bautista-Gonz ález David Heredia Jenny G Turcott Feliciano Barr ón Maritza Ramos-Ram írez Luis Cabrera-Miranda Miguel Ángel Salinas Padilla Mercedes Aguerrebere Andr és F Cardona Christian Rolfo Marisol Arroyo-H Source Type: research